The use of vaccines for prevention of seasonal and pandemic influenzaArchived
On 3 October 2011 European Centre for Disease Prevention and Control (ECDC) and representatives of the European Vaccine Manufacturers met at ECDC in Stockholm for a regular scheduled meeting about the use of vaccines for prevention of seasonal and pandemic influenza. ECDC Director Marc Sprenger opened the meeting and ECDC influenza experts held different presentations, such as burden of influenza disease in the EU, risk groups for severe influenza disease, personal protective measures, pandemic influenza preparedness, seasonal influenza vaccines, communication.
The Declarations of Interest for ECDC Influenza Staff and the ECDC Director are available here under ECDC Transparency.
Development of public health programmes for prevention and control of seasonal influenzaArchived
ECDC training programme workshop on “Development of public health programmes for prevention and control of seasonal influenza” took place in Stockholm 8-10 October 2012.
Expert consultation on the evidence base of public health use of antivirals for prevention and treatment of influenza
Neuraminidase inhibitors, commonly referred to as antivirals, have been subject to much debate about the effectiveness in preventing and treating influenza. ECDC convened a meeting of experts in order to review and discuss evidence regarding antivirals.
The United States Advisory Committee on Immunization Practices votes for near universal recommendation for seasonal influenza vaccinationArchived
The United States Advisory Committee on Immunization Practices (ACIP), which advises the Centers for Disease Control and Prevention (CDC) on vaccine issues, voted to approve a new recommendation on February 24 to offer seasonal influenza vaccination to the whole population aged 6 months and older.
Obesity and 2009 pandemic influenza A(H1N1) – its role and implications as an important risk factor for the development of severe influenza diseaseArchived
2 papers are reviewed: A Novel Risk Factor for a Novel Virus: Obesity and 2009 Pandemic Influenza A (H1N1) and Morbid Obesity as a Risk Factor for Hospitalization and Death Due to 2009 Pandemic Influenza A(H1N1) Disease.
Virological Risk Assessment of Pandemic Potential - EFSA Call for proposalsArchived
The European Food Standard Agency has recently published a call for proposals for a methodological framework for potentially pandemic influenza strains.